🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Loved presenting our MDACC institutional study of NSCLC patients with LMD at my first WCLC, and excited to continue future efforts in this area of huge unmet need! #WCLC24 Xiuning Le MD PhD

So proud of Kelsey Pan, MD, MPH MD Anderson Cancer Center and everything she is doing! #WCLC24 IASLC

Jeffrey S Weber's life is a testament to mentorship, patient care, sacrifice, leadership. Thank you Journal for ImmunoTherapy of Cancer for allowing us to share a glimpse of this giant. jitc.bmj.com/content/12/9/e… Jason Luke, MD, FACP Bernard A Fox Moffitt Cancer Center USC Norris Comprehensive Cancer Center NYU Langone Health National Cancer Institute ASCO Melanoma Research Foundation

Study From Researchers at Fox Chase Cancer Center and Johns Hopkins Kimmel Cancer Center Shows Aged Male Fibroblasts Increase Melanoma Treatment Resistance Fox Chase Cancer Center #melsm #oncology #MedTwitter onclive.com/view/study-fro…

Congratulations to star cofellow Nazli Dizman!! Highly deserved recognition 👏🏻👏🏻 MD Anderson Cancer Center

Dr. Allison Betof Warner Allison Betof Warner, MD, PhD presenting on Lifileucel for treating #melanoma brain metastases, with plans for an expansion to further evaluate safety and efficacy! #SMR24 Society For Melanoma Research

It is with deep sorrow that we bid our brother Emmanuel Almanza-Huante farewell today. A brilliant leukemia physician MD Anderson Cancer Center whose light shone so bright; the world is so much darker now. Please donate to help his family, whom he supported, with costs: gofund.me/f8e20f32

Had an amazing time at the #SITC SCION workshop in Austin! Learned so much about clinical protocol development from true experts in the field. Grateful for the opportunity to connect, learn and grow with such a talented group! Society for Immunotherapy of Cancer #SCION

Proud of this Australian study led Melanoma Institute Australia that changed practice overnight - now the 7 year overall survival in patients with #melanoma brain metastases. 51% alive at 7 yrs for upfront combination ipi+nivo & 29% for nivo mono therapy. University of Sydney Australian Academy of Science

And just like that, I’m already a lame duck chief. Congrats to our new MD Anderson Cancer Center heme/onc fellowship chiefs for 2025-2026: Jen Marvin-Peek, MD Michael LaPelusa, MD Hannah Goulart Sushanth Gouni Laura Amin, MD Tony Zhuang

Congratulations to my friend and MD Anderson Cancer Center co-fellow Inimfon Jackson on her award, LBJ 2nd year fellow of the year! So well deserved! 🤩✨👏🏼

Huge congratulations to our incredible mentor, Dr. Mariana Chavez MacGregor, on being named MD Anderson Cancer Center Mentor of the Year! I’m greatly appreciative of your guidance, unwavering support and sponsorship. So well deserved! ✨

Strong work form MD Anderson Cancer Center co-fellow Afsaneh Amouzegar, MD understanding KIT mutations and risk of CNS metastases in mucosal melanoma. #ASCO2025 #endcancer

Insightful work from my MD Anderson Cancer Center co-fellow and friend Afsaneh Amouzegar, MD on the association between KIT mutations and CNS metastases in mucosal melanoma. #ASCO25

Huge congrats to my friend and MD Anderson Cancer Center cofellow Ryan Denu, MD, PhD on his oral presentation at #ASCO25, identifying two new leiomyosarcoma subtypes with distinct biology and immune profiles using spatial transcriptomics. Incredible work!

The breast onc sisters meet the Oncology Brothers at #MiamiNights #ASCO25

Cindy Y. Jiang is doing some impressive work on MTAP loss in bladder cancer. Come check it out. MD Anderson Cancer Center #ASCO25 #endcancer

Huge congratulations to my friend and MD Anderson Cancer Center co-fellow Marija Sullivan, MD on her impactful work looking at the real-world patterns of Oncotype testing & chemo use in early-stage HR+ breast cancer #ASCO25

Amazing work presented by my friend and MD Anderson Cancer Center co-fellow Cindy Y. Jiang on the 9p21-loss story in bladder cancer. Targeting the TGFB pathway may be the path forward for improving outcomes in this aggressive cancer type! #ASCO25

We’re very proud of our MD Anderson Cancer Center heme/onc fellows Neha Akkad Nazli Dizman Cindy Y. Jiang Jen Marvin-Peek, MD Hila Shaim Inimfon Jackson Paulino Tallón de Lara MD, PhD Ranjan Upadhyay Michael Wotman Jenny Xiang Michael LaPelusa, MD Nakul Shah